Skip to content

A comparative study of different doses of remimazolam combined with fentanyl in painless oocyte retrieval

A comparative study of different doses of remimazolam combined with fentanyl in painless oocyte retrieval

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076264
Enrollment
Unknown
Registered
2023-09-28
Start date
2023-09-30
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesiology

Interventions

Group R1:Remimazolam besylate 0.2mg/kg combined with Alfentanyl 5ug/kg
Group P:Propofol 2mg/kg combined with Alfentanyl 5ug/kg
Group R2:Remimazolam besylate 0.3mg/kg combined with Alfentanyl 5ug/kg
Group R3:Remimazolam besylate 0.4mg/kg combined with Alfentanyl 5ug/kg

Sponsors

Hospital of Reproductive Medicine Affiliated to Shandong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: ?20=age =45 years; ?18.5 kg/m2 < body mass index (BMI) < 27.9 kg/m; ?American Society of Anesthesiologists [ASA] classification I or II ; ?Patients undergoing ultrasound-guided transvaginal egg retrieval; ?Patients clear understanding and voluntary participation in the study and signed informed consent form.

Exclusion criteria

Exclusion criteria: ?Patients with contraindications to deep sedation/general anesthesia or a history of sedation/anesthesia accidents; ?Allergy or contraindication to benzodiazepines, opioids, propofol, lidocaine, and other drugs and their components; ?Modified Mallampati Score with grade III and above; ?The number of dominant follicles was > 20 or < 3; ?History of mental disorder or psychological disorder, recent use of antipsychotic drugs or antidepressant drugs; ?History of PONV; ?Long-term use of sleeping pills or sedative drugs.

Design outcomes

Primary

MeasureTime frame
Success rate of sedation;

Secondary

MeasureTime frame
General information of patients;Hemodynamics index;Time from the start of drug administration to the first MOAA/S score < 2;Recovery time;Time to fully allert;The number and grade of intraoperative body movements;Intraoperative drug dosage;Adverse reaction;Time of Operation ;

Countries

China

Contacts

Public ContactXin Zhang

Hospital of Reproductive Medicine Affiliated to Shandong University

xinnnn@live.cn+86 155 8881 1144

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026